COMMENTARY
Is It Possible to Detect the Pathogenesis of Cardiac Amyloidosis by Echocardiography?
First published: 24 April 2025
No abstract is available for this article.
References
- 1R. M. Witteles and M. Liedtke, “AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management,” JACC CardioOncology 1 (2019): 117–130.
- 2J. Koyama, S. Ikeda, and U. Ikeda, “Echocardiographic Assessment of the Cardiac Amyloidoses,” Circulation Journal 79 (2015): 721–734.
- 3D. Dima, S. Mazzoni, F. Anwer, et al., “Diagnostic and Treatment Strategies for AL Amyloidosis in an Era of Therapeutic Innovation,” JCO Oncology Practice 19 (2023): 265–275.
- 4Y. Saijo, H. Yamada, N. Yamaguchi, et al., “Diagnostic Utility of Relative Apical Sparing Index in Cardiac Amyloidosis Subtypes: A Comparative Study of Immunoglobulin Light Chain and Transthyretin Amyloid Cardiomyopathy,” Echocardiography 42 (2025): e70087.
- 5S. H. Barberato, B. ALdS, V. T. Hotta, and R. DdC, “A Critical Review of Echocardiographic Findings for Diagnosing Cardiac Amyloidosis,” International Journal of Cardiovascular Sciences (2024): 37, https://doi.org/10.36660/ijcs.20240047.
- 6J. P. Sun, W. J. Stewart, X. S. Yang, et al., “Differentiation of Hypertrophic Cardiomyopathy and Cardiac Amyloidosis From Other Causes of Ventricular Wall Thickening by Two-Dimensional Strain Imaging Echocardiography,” American Journal of Cardiology 103 (2009): 411–415.
- 7L. Chacko, R. Martone, F. Bandera, et al., “Echocardiographic Phenotype and Prognosis in Transthyretin Cardiac Amyloidosis,” European Heart Journal 41 (2020): 1439–1447.
- 8G. Bazoukis, A. Saplaouras, P. Efthymiou, et al., “Atrial Fibrillation in the Setting of Cardiac Amyloidosis—A Review of the Literature,” Journal of Cardiology 84 (2024): 155–160.
- 9C. Nitsche, P. R. Scully, K. P. Patel, et al., “Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis,” American Journal of Cardiology 77 (2021): 128–139.
- 10 Writing C, M. M. Kittleson, F. L. Ruberg, et al., “2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee,” American Journal of Cardiology 81 (2023): 1076–1126.
